Care after breast reconstruction
Farida ALI
Quelles stratégies thérapeutiques employer dans les pays émergents ?
Joseph GLIGOROV
Oncologue, Paris, France
HR+/HER2- non-metastatic disease adjuvant management in 2022.
Marc SPIELMANN, Joseph GLIGOROV
Innovations in breast metastatic cancer
Frédérique PENAULT LLORCA Pathologist, Clermont Ferrand, France
Anticipating survivorship from the moment of cancer diagnosis
Marilyne Baranes